On Friday, Shares of SanDisk Corporation (NASDAQ:SNDK), lost -2.73% to $62.36. The stock attained the volume of 3.85 million shares.
SanDisk Corporation (SNDK), a global leader in flash storage solutions, and HP (HPQ) recently declared a long-term partnership to collaborate on a new technology within the Storage Class Memory (SCM) category. The partnership will center around HP’s Memristor technology and expertise and SanDisk’s non-volatile ReRAM memory technology and manufacturing and design expertise to create new enterprise-wide solutions for Memory-driven Computing. The two companies also will partner in enhancing data center solutions with Solid State Drives (SSDs).
The technology is predictable to be up to 1,000 times faster than flash storage and offer up to 1,000 times more endurance than flash storage. It also is predictable to offer noteworthy cost, power, density and persistence improvements over DRAM technologies. The SCM technology and its characteristics are intended to allow systems to employ tens of terabytes (TB) of SCM per server node for applications such as in-memory databases, real-time data analytics, transactional and high-performance computing.
SanDisk Corporation designs, develops, manufactures, and markets data storage solutions in the United States and internationally. The company offers removable cards, which are used in various applications and consumer devices, counting digital cameras, camcorders, smartphones, tablets, and eReaders under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; and embedded products that are used in mobile phones, tablets, notebooks, and other portable and wearable devices, in addition to in automotive and connected home applications under the brand name iNAND.
Shares of Allergan PLC (NYSE:AGN), dropped -0.42% to $275.01, during its last trading session.
Allergan plc (AGN) declared that the U.S. Food and Drug Administration (FDA) has accepted for filing Allergan’s supplemental New Drug Application (sNDA). This filing will expand the label to comprise single-dose administration of DALVANCE® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults caused by designated susceptible Gram-positive bacteria, counting methicillin-resistant Staphylococcus aureus (MRSA).
The application was based on results from a Phase 3 study DUR001-303, which contrast a single 1500 mg dose of DALVANCE with the two-dose regimen of 1000 mg followed one week later by 500 mg. Data demonstrated the 1500 mg single dose of DALVANCE achieved its primary endpoint of non-inferiority to the two-dose regimen (10% non-inferiority margin) at 48 to72 hours after initiation of therapy, as determined by a decrease of > 20% in lesion area relative to the baseline measurement (81.4% vs. 84.2% for the single dose vs. the two dose regimen, respectively; Difference -2.9; 95% CI: -8.5, 2.8).
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution.
Finally, Molson Coors Brewing Company (NYSE:TAP), ended its last trade with -0.48% loss, and closed at $81.61.
Molson Coors Brewing Company ( TAP) will host an online, real-time webcast of the company’s 2015 Third Quarter Earnings Conference Call with financial analysts at 11:00 a.m. Eastern Time (9:00 a.m. Mountain Time) on Thursday, November 5, 2015. The company will release earnings at about 6:45 a.m. Eastern Time on the same day. Company executives participating in the conference call will comprise Mark Hunter, Chief Executive Officer, and Gavin Hattersley, Chief Financial Officer (and Chief Executive Officer of MillerCoors).
About one hour after the conclusion of the regular earnings call, the company will also host an online, real-time webcast of the Investor Relations Follow-up Session for financial analysts at 1:00 p.m. Eastern Time (11:00 a.m., Mountain Time).
Molson Coors Brewing Company manufactures and sells beer and other beverage products. The company sells its products under the Coors Light, Molson Canadian, Carling, Carling Black Label, Coors Altitude, Coors Banquet, Creemore Springs, the Granville Island, Keystone Light, Mad Jack, Molson Canadian 67, Molson Canadian Cider, Molson Dry, Molson Export, Pilsner, and the Rickard’s family brands in Canada; and brews or distributes under the Amstel Light, Heineken, Murphy’s, Newcastle Brown Ale, Strongbow cider, Desperados, Dos Equis, Moretti, Sol, Tecate, Miller Chill, and Miller Genuine Draft brands.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
